BMRN PDUFA decision: a positive outcome, +10.3%

On November 19, 2021, Voxzogo — BioMarin Pharmaceutical Inc. (Achondroplasia) reached its PDUFA decision. The result was a positive outcome, and the stock moved +10.3% in the window around the event. It had already run +8.2% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.